POAI Predictive Oncology Inc.: Nilai perusahaan marang pendapatan

Simbol resmi perusahaan Predictive Oncology Corp (POAI)

How can a unique bio-sample archive for cancer therapy selection be effectively monetized? The EV-to-revenue ratio on the precise GURU.Markets chart for Predictive Oncology (POAI), where the value is fixed at 30000.00, demonstrates the asset's dynamics. Stability is ensured by the non-cyclical nature of long-term AI development funding, while the business's sustainability is supported by digital modeling that reduces the number of physical chemical tests.

Predictive Oncology Inc (POAI): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 12.12.2025

POAI (Predictive Oncology Inc): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis wiwitan perusahaan:Predictive Oncology Corp
Produk sing diprodhuksi Predictive Oncology Inc.

This indicator measures the enterprise value—business market value plus net debt—comparing this total capital to annual revenue to eliminate distortions caused by leverage. By analyzing the current price-to-sales valuation of Predictive Oncology (POAI), an investor can determine the extent to which the market is overvaluing the potential of the company's AI platform for tumor response modeling and its unique biosample database, which creates high barriers to entry for competitors.

Analisis pesaing

ISRG - Multiplikator EV/Sales|DHR: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan BD (BDX)|Rasio nilai perusahaan marang pendapatan STERIS plc|Rasio nilai perusahaan marang pendapatan WST (West Pharmaceutical Services)|Nilai perusahaan marang pendapatan BAX (Baxter Corp)|Masimo - Rasio nilai perusahaan marang pendapatan|Stevanato Group S.p.A. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Teleflex Inc (TFX)|MMSI - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Envista Holdings Corp NVST|ICUI: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XRAY|LMAT (LeMaitre Corp) - Multiplikator EV/Sales|ATRC (AtriCure Inc) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales STAA|NAGE (ChromaDex Corp) - Nilai bisnis marang pendapatan|ZimVie Inc. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan angiodynamics.com (ANGO)|CERS - Rasio nilai perusahaan marang pendapatan|TKNO - Multiplikator EV/Sales|Monogram Technologies Inc (MGRM) - Rasio nilai perusahaan marang pendapatan|STSS - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan InfuSystem Holdings, Inc.|Multiplikator nilai perusahaan marang pendapatan Utah Medical Products UTMD|Multiplikator EV/Sales KRMD|Rasio total nilai perusahaan marang pendapatan Nyxoah, S.A.|Microbot Medical Inc - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Pro-Dex Inc. (PDEX)|Zentek - Multiplikator EV/Sales|Elutia (ELUT) - Nilai perusahaan marang pendapatan|Milestone Scientific Inc (MLSS) - Rasio nilai perusahaan marang pendapatan|NXGL - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan RVP|Harvard Bioscience, Inc. (HBIO) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales FEMY|Multiplikator EV/Sales Meihua Medical Technologies (MHUA)|Multiplikator EV/Sales CJMB (Callan JMB Inc)|Multiplikator EV/Sales Atrion Corp ATRI|NeuroMetrix Corporation - Multiplikator EV/Sales